2 weeks Ago
A renewed attack on medication abortion is threatening nationwide access to mifepristone, one of two drugs used to terminate a pregnancy. The new legal filing, from state attorneys general in Idaho, Kansas and Missouri, poses a direct threat to mail-order delivery of the drug. It’s a last-minute reminder of what’s at stake for women’s health in this year’s election — in which voting has already begun.
If this sounds eerily familiar, it’s for good reason. The Supreme Court in June rejected an earlier version of the case, filed by a group of Texas doctors, based on standing, meaning they were not harmed by the drug and had no grounds to sue. Normally, the case would then be dismissed by the lower courts, following the high court’s guidance, explains David Cohen, a law professor at Drexel University.
Javascript is required for you to be able to read premium content. Please enable it in your browser settings..
